Výsledky vyhledávání - "Ana Roxo Ribeiro"

Smoking as associated factor for spondyloarthritis related uveitis: results from a single centre cross-sectional study

Autor: Emanuel, Costa, Diogo, Almeida, Marcos, Cerqueira, José Redondo, Costa, Ana Roxo, Ribeiro, Joana, Sousa-Neves

Publikováno v: Acta Reumatológica Portuguesa, Vol 2020, Iss 4, Pp 265-269 (2020)

Ocular involvement in spondyloarthritis (SpA) is a frequent extra-articular manifestation and contributes to the burden of disease. Factors associated with spondyloarthritis-related uveitis (SpA-U) are poorly defined in literature. The influence of s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::01b377590f26665602e74dadd2c3546d
http://www.actareumatologica.pt/files/article/1333_smoking_as_associated_factor_for_spondyloarthritis_related_uveitis_results_from_a_single_centre_cross_sectional_study__file.pdf

Zobrazit plný text záznamu

Chikungunya arthritis - should we expect it to become more common in Portuguese rheumatology?

Autor: Diogo Esperança Almeida, Emanuel Costa, Ana Sofia Pinto, Joana Leite Silva, Joana Sousa Neves, Ana Roxo Ribeiro, Marcos Cerqueira

Publikováno v: Acta Reumatológica Portuguesa, Vol 2020, Iss 4, Pp 298-300 (2020)

Chikungunya virus is known to cause acute disease characterized by fever, rash, myalgias, conjunctivitis and arthritis, having potential to cause chronic musculoskeletal disease, namely persistent arthritis. The area of spread of the virus in the wor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doajarticles::51331a0a0fb7f3b4430163f103793b42
http://www.actareumatologica.pt/files/article/1338_chikungunya_arthritis_should_we_expect_it_to_become_more_common_in_portuguese_rheumatology__file.pdf

Zobrazit plný text záznamu

Are we overlooking osteoarthritis? - A comparative study of pain, function and quality of life in patiens with hand osteoarthritis and rheumatoid arthritis

Autor: Diogo Esperança Almeida, Emanuel Costa, Francisca Guimarães, Soraia Azevedo, Joana Rodrigues, Joana Leite Silva, Daniela Santos Faria, Daniela Peixoto, Filipa Teixeira, José Tavares Costa, Carmo Afonso, Joana Sousa Neves, Ana Roxo Ribeiro, Marcos Cerqueira

Publikováno v: Acta Reumatológica Portuguesa, Vol 2020, Iss 3, Pp 233-234 (2020)

Osteoarthritis (OA) is frequently regarded by patients and health care providers as a normal consequence of ageing and a minor condition. In contrast, rheumatoid arthritis (RA) is a pathological condition that usually requires prolonged treatment and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ab78de81cab78d731ebabe37ff2a5532
https://pubmed.ncbi.nlm.nih.gov/33139677

Zobrazit plný text záznamu

Cutaneous vasculitis and granulomatous hepatitis as paradoxical adverse events of Infliximab

Autor: DIogo Esperança Almeida, Emanuel Costa, Joana Sousa Neves, Marcos Cerqueira, Ana Roxo Ribeiro

Publikováno v: Acta Reumatológica Portuguesa, Vol 2020, Iss 2, Pp 156-157 (2020)

Biological agents revolutionised the treatment of inflammatory arthropathies. Paradoxical adverse events (PAEs) are rare immunological side effects caused by such agents. The authors report concurrent presentation of two rare PAEs of tumor-necrosis-f

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doajarticles::11163fa7f1dcfd571cc6fdadc93212fb
http://www.actareumatologica.pt/files/article/1309_cutaneous_vasculitis_and_granulomatous_hepatitis_as_paradoxical_adverse_events_of_infliximab_file.pdf

Zobrazit plný text záznamu

Rituximab in connective tissue disease-associated interstitial lung disease

Autor: Ana Catarina, Duarte, Ana, Cordeiro, Bruno Miguel, Fernandes, Miguel, Bernardes, Patrícia, Martins, Inês, Cordeiro, Tânia, Santiago, Maria Inês, Seixas, Ana Roxo, Ribeiro, Maria José, Santos

Publikováno v: Clinical rheumatology. 38(7)

To evaluate rituximab (RTX) effectiveness and safety in patients with interstitial lung disease (ILD) related to connective tissue diseases (CTD).Retrospective multicenter cohort study, including patients with CTD-ILD, followed in six Portuguese rheu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::fc398ad580e1a097059a66ef6134639f
https://pubmed.ncbi.nlm.nih.gov/31016581

Zobrazit plný text záznamu

Rituximab in connective tissue disease–associated interstitial lung disease

Autor: Ana Catarina Duarte, Patrícia Martins, Ana Roxo Ribeiro, Ana Cordeiro, I. Cordeiro, Miguel Bernardes, Maria Inês Seixas, Tânia Santiago, Maria José Santos, Bruno Miguel Fernandes

© International League of Associations for Rheumatology (ILAR) 2019
Introduction/objectives: To evaluate rituximab (RTX) effectiveness and safety in patients with interstitial lung disease (ILD) related to connective tissue diseases (CTD). Meth

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8652f3aeb81c6955828db0addc675e93
https://hdl.handle.net/10451/52957

Zobrazit plný text záznamu

Portuguese recommendations for the use of biological and targeted synthetic diseasemodifying antirheumatic drugs in patients with rheumatoid arthritis – 2020 update

Autor: Bruno Miguel Fernandes, Francisca Guimarães, Diogo Esperança Almeida, Agna Neto, José Tavares-Costa, Ana Roxo Ribeiro, Alberto Quintal, Joaquim Polido Pereira, Lígia Silva, Teresa Sampaio da Nóvoa, Augusto Faustino, Cláudia Vaz, Nikita Khmelinskii, Beatriz Samões, Eduardo Dourado, Joana Leite Silva, Anabela Barcelos, Eva Mariz, Miguel Guerra, Maria José Santos, Manuel Silvério-António, Rui Lourenço Teixeira, Romão, Vasco C., Helena Santos, Daniela Santos-Faria, Soraia Azevedo, Ana Rodrigues, João Madruga Dias, Carina Lopes, Patrícia Pinto, Maura Couto, Miranda, Luís C., Alexandra Bernardo, Margarida Cruz, Filipa Teixeira, Ana Filipa Mourão, Adriano Neto, Victor Teixeira, Ana Cordeiro, Sofia Barreira, Inês, Luís S., Susana Capela, Alexandre Sepriano, Helena Canhão, João Eurico Fonseca, Cátia Duarte, Miguel Bernardes

Publikováno v: Scopus-Elsevier
Universidade Nova de Lisboa

Objective: To update the recommendations for the treatment of rheumatoid arthritis (RA) with biological and targeted synthetic disease-modifying antirheumatic drugs (bDMARDs and tsDMARDs), endorsed by the Portuguese Society of Rheumatology (SPR). Met

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::08ef163675659130eb20687d005879f0
http://www.scopus.com/inward/record.url?eid=2-s2.0-85126145025&partnerID=MN8TOARS

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání